Analysts expect Cantel Medical Corp. (NYSE:CMD) to report sales of $250.70 million for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Cantel Medical’s earnings, with the highest sales estimate coming in at $253.70 million and the lowest estimate coming in at $247.70 million. Cantel Medical posted sales of $225.59 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 11.1%. The company is expected to report its next earnings report before the market opens on Tuesday, December 10th.
On average, analysts expect that Cantel Medical will report full year sales of $1.16 billion for the current fiscal year. For the next year, analysts expect that the firm will report sales of $1.28 billion, with estimates ranging from $1.28 billion to $1.29 billion. Zacks’ sales averages are an average based on a survey of research analysts that that provide coverage for Cantel Medical.
Cantel Medical (NYSE:CMD) last released its quarterly earnings results on Monday, September 23rd. The company reported $0.63 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.61 by $0.02. The firm had revenue of $239.48 million for the quarter, compared to the consensus estimate of $238.60 million. Cantel Medical had a return on equity of 15.34% and a net margin of 5.99%.
Shares of CMD stock traded down $0.26 on Monday, hitting $77.77. 173,489 shares of the stock were exchanged, compared to its average volume of 263,572. The company has a current ratio of 2.32, a quick ratio of 1.41 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $3.32 billion, a P/E ratio of 32.84 and a beta of 1.00. Cantel Medical has a fifty-two week low of $63.47 and a fifty-two week high of $93.87. The business has a 50-day moving average of $73.19 and a 200 day moving average of $78.22.
Cantel Medical Company Profile
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.
See Also: Why are percentage gainers important?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.